First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases

AIDS. 2006 Feb 14;20(3):471-3. doi: 10.1097/01.aids.0000199826.72359.9d.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Enfuvirtide
  • HIV Envelope Protein gp41 / therapeutic use*
  • HIV Fusion Inhibitors / therapeutic use*
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments / therapeutic use*
  • Treatment Outcome
  • Viral Load

Substances

  • HIV Envelope Protein gp41
  • HIV Fusion Inhibitors
  • Peptide Fragments
  • Enfuvirtide